Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Aarhus
About this trial
The purpose of the present study is to evaluate the role of peripheral afferent input for spontaneous pain in painful diabetic polyneuropathy
Eligibility criteria
Qualifiers
Aged 18 years or older.
Probably diabetic neuropathy confirmed using the Toronto criteria in a "conservative manner", i.e. three out of three symptoms/signs of neuropathy must be present (sensory neuropathy symptoms, distal reduced sensibility, reduced ankle reflexes) 7.
Definite or probable neuropathic pain for minimum the last 6 months
Mean pain intensity at > 4 NRS the last week17.
Disqualifiers
Other causes of pain in the same area or other pain that cannot be distinguished from the neuropathic pain.
Unable to understand and speak Danish.
Non-cooperative.
Warfarin or other medication that contraindicate regional anesthesia.
Trial design
Treatments tested in this trial
- Xylocaine 1%
- NaCl 9mg/ml
Treatment groups
16 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov